A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety and efficacy of sibutramine in preventing
binge eating episodes. Additionally the study aim is to evaluate the safety and efficacy of
sibutramine in reducing body weight in subjects with binge-eating disorder.